论文信息 - Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis - 字舞流文

Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis

S. Shim | C. Suh | J. Choe | W. Park | L. Myasoutova | P. Wiland | S. Radominski | S. Jeka | Sung Hwan Kim | M. Lim | M. Stanislav | S. Y. Lee | P. Hrycaj | Sang Joon Lee | P. Shesternya | V. Kovalenko | Eun Young Lee | F. F. C. Molina | D. Yoo | F. Medina-Rodriguez